USMLE Step 1 Hematology and Oncology High-Yield Facts

Mastering hematology and oncology is non-negotiable for USMLE Step 1 success. These topics are heavily tested, not in isolation, but through complex clinical vignettes that demand you integrate pathophysiology with lab data interpretation. A strong foundation here will allow you to efficiently diagnose blood disorders and cancers from a paragraph of clues, directly translating to points on the exam.

Foundational Frameworks: Anemia and Coagulation

Your diagnostic journey begins with a structured approach to anemia, a reduction in the oxygen-carrying capacity of blood. The first critical step is classifying it by mean corpuscular volume (MCV) as microcytic, normocytic, or macrocytic. For microcytic anemia, think "TAIL": Thalassemia, Anemia of chronic disease, Iron deficiency, and Lead poisoning. Key discriminators include the red cell distribution width (RDW), which is high in iron deficiency (anisocytosis) but normal in thalassemia. You'll often be asked to interpret iron studies: low serum iron and ferritin with high TIBC points to iron deficiency, while high ferritin with low TIBC suggests anemia of chronic disease.

The coagulation cascade is a classic Step 1 topic. Remember it as a series of amplifying enzymatic reactions culminating in fibrin clot formation. It's divided into the intrinsic, extrinsic, and common pathways. Clinically, the PT/INR tests the extrinsic (Factor VII) and common pathways, while the aPTT tests the intrinsic (Factors XII, XI, IX, VIII) and common pathways. A bleeding patient with a prolonged aPTT but normal PT immediately narrows your differential to issues like hemophilia A (Factor VIII deficiency) or the presence of an inhibitor like heparin. Understanding this logic is more valuable than memorizing every factor.

Platelet Disorders and Peripheral Smear Mastery

Platelet disorders present with mucocutaneous bleeding (petechiae, epistaxis) and a prolonged bleeding time. Key distinctions are crucial. Immune thrombocytopenic purpura (ITP) is an autoimmune destruction of platelets, often post-viral in children or primary in adults, presenting with isolated thrombocytopenia and normal PT/PTT. In contrast, thrombotic thrombocytopenic purpura (TTP) is a true hematologic emergency caused by a deficiency of ADAMTS13, leading to unchecked platelet aggregation. It presents with the classic pentad: thrombocytopenia, microangiopathic hemolytic anemia (seen on smear), fever, renal dysfunction, and neurologic symptoms. The smear finding of schistocytes (fragmented RBCs) is the high-yield clue differentiating TTP from ITP.

This leads directly to peripheral blood smear interpretation, a visual skill you must develop. You will be shown images or given classic descriptions. Know these associations cold: Howell-Jolly bodies (spheric nuclear remnants) indicate hyposplenism or splenectomy; Heinz bodies (denatured hemoglobin) are seen in G6PD deficiency; Auer rods (azurophilic granules) are pathognomonic for acute myeloid leukemia (AML); and Reed-Sternberg cells (owl-eyed nuclei) are the hallmark of Hodgkin lymphoma. A smear showing sickled cells is diagnostic for sickle cell disease, while target cells suggest liver disease or thalassemia.

Leukemia, Lymphoma, and Tumor Biology

Distinguishing the major leukemia-lymphoma types is a high-frequency theme. Acute leukemias (AML, ALL) present with a rapid onset of cytopenias (anemia, infection, bleeding) and often high white counts with blast cells on smear. Acute lymphoblastic leukemia (ALL) is the most common childhood leukemia, associated with lymphoblasts that may show positive terminal deoxynucleotidyl transferase (TdT). Acute myeloid leukemia (AML) is more common in adults and is defined by the presence of Auer rods and myeloblasts. For Step 1, the translocation t(15;17) in acute promyelocytic leukemia (APL), a subtype of AML, is vital. It creates the PML-RARA fusion protein, treats uniquely with all-trans retinoic acid (ATRA), and presents with DIC.

Chronic leukemias, like chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML), have a more indolent course. CML is defined by the Philadelphia chromosome, t(9;22), creating the BCR-ABL oncogene, and is treated with tyrosine kinase inhibitors like imatinib. Lymphomas are solid tumors of lymphocytes. The key distinction: Hodgkin lymphoma has Reed-Sternberg cells in a background of reactive inflammatory cells, often presents with contiguous lymph node spread, and has bimodal age distribution. Non-Hodgkin lymphomas are a diverse group (e.g., Diffuse Large B-Cell Lymphoma, Burkitt lymphoma) that typically spread non-contiguously.

Oncologic Principles: Markers, Syndromes, and Chemotherapy

Tumor marker associations are pure recall but frequently tested. Use them for monitoring, not screening. Key ones include: PSA for prostate cancer, CA-125 for ovarian cancer (especially epithelial), CA 19-9 for pancreatic cancer, CEA for colorectal cancer, AFP for hepatocellular carcinoma and yolk sac tumors, and Beta-hCG for gestational trophoblastic disease and some germ cell tumors.

Paraneoplastic syndromes are remote effects of a cancer, not from metastasis. They are crucial diagnostic clues. Classic pairings are: SIADH (hyponatremia) with small cell lung cancer; Cushing syndrome (ectopic ACTH) also with small cell lung cancer; Hypercalcemia (PTHrP) with squamous cell lung cancer and multiple myeloma; Lambert-Eaton myasthenic syndrome (proximal muscle weakness) with small cell lung cancer; and Polycythemia (erythropoietin) with renal cell carcinoma and hepatocellular carcinoma.

Understanding chemotherapy drug mechanisms allows you to predict side effects. Alkylating agents (e.g., cyclophosphamide) cross-link DNA, causing bone marrow suppression and hemorrhagic cystitis (prevented with mesna). Antimetabolites (e.g., methotrexate, 5-fluorouracil) inhibit nucleotide synthesis; methotrexate specifically inhibits dihydrofolate reductase, and its toxicity is rescued with leucovorin. Plant alkaloids have specific neurotoxicities: vincristine causes peripheral sensory neuropathy, while paclitaxel can cause an acute hypersensitivity reaction. Doxorubicin, an anthracycline, is cardiotoxic and can cause dilated cardiomyopathy. Bleomycin causes pulmonary fibrosis.

Common Pitfalls

1. Mixing up DIC and TTP: Both can cause thrombocytopenia and schistocytes. Disseminated intravascular coagulation (DIC) is a consumptive process triggered by sepsis, trauma, or obstetrical calamities. It consumes both platelets and coagulation factors, so you see prolonged PT/PTT, elevated D-dimer, and low fibrinogen. TTP has normal coagulation times and fibrinogen. If the vignette describes an obstetric patient with heavy bleeding and abnormal coagulation studies, it's DIC. If it's a patient with confusion and normal PT/PTT, think TTP.

1. Confusing Leukemoid Reaction with CML: Both present with very high WBC counts. A leukemoid reaction is a benign, reactive process to infection or inflammation. The key is the presence of a high leukocyte alkaline phosphatase (LAP) score and a "left shift" with mature cells and few blasts. CML has a low LAP score, a full spectrum of myeloid cells from blasts to mature neutrophils on smear, and is confirmed by the Philadelphia chromosome.

1. Misinterpreting Iron Studies in Anemia of Chronic Disease (ACD): Students often remember ACD as having "low iron." While serum iron is low, the critical differentiator from iron deficiency is that ferritin (an acute phase reactant) is normal or high, and TIBC is low because the body is sequestering iron, not lacking it. In iron deficiency, ferritin and serum iron are low, and TIBC is high.

1. Attributing All Tumor-Related Hypercalcemia to Bone Metastases: While bone metastases are a common cause, the most classic paraneoplastic cause is secretion of PTH-related peptide (PTHrP) by tumors like squamous cell lung cancer. This presents as hypercalcemia with low PTH on lab work. Don't automatically default to metastatic disease without considering this high-yield syndrome.

Summary

• Systematically classify anemia by MCV and use iron studies (serum iron, ferritin, TIBC) and RDW to distinguish between iron deficiency, anemia of chronic disease, and thalassemia.
• Use PT/PTT patterns to diagnose coagulation disorders: isolated aPTT prolongation suggests hemophilia or heparin effect, while prolongation of both suggests a common pathway problem (e.g., warfarin, DIC, liver disease) or a combined deficiency.
• Differentiate platelet disorders: ITP has isolated thrombocytopenia, while TTP presents with thrombocytopenia, schistocytes on smear, and neurologic/renal involvement. Memorize high-yield peripheral smear findings (Auer rods, Reed-Sternberg cells, schistocytes).
• Distinguish acute leukemias (ALL in kids, AML in adults; Auer rods in AML) and know the Philadelphia chromosome for CML. Differentiate Hodgkin (Reed-Sternberg cells, contiguous spread) from Non-Hodgkin lymphoma.
• Know the classic paraneoplastic syndromes (e.g., SIADH/hypercalcemia with lung cancers) and tumor markers (PSA, CA-125, AFP) for monitoring. Link chemotherapy drug classes to their signature toxicities (e.g., hemorrhagic cystitis with cyclophosphamide, pulmonary fibrosis with bleomycin, cardiotoxicity with doxorubicin).